Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.
Follow CHE
Chemed Corporation (CHE) Altman Z-score
Chemed Corporation's Altman Z-score for fiscal 2025 is 11.69, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 11.69 | (1.55) |
| FY2024 | 13.23 | (0.41) |
| FY2023 | 13.65 | 2.16 |
| FY2022 | 11.49 | 0.15 |
| FY2021 | 11.34 | (2.27) |
| FY2020 | 13.61 | 2.13 |
| FY2019 | 11.47 | 0.00 |
| FY2018 | 11.48 | 1.53 |
| FY2017 | 9.94 | 1.53 |
| FY2016 | 8.41 | 0.02 |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.01 | — | 0.01 | |
| Retained earnings / total assets | 1.92 | — | 2.69 | |
| EBIT / total assets | 0.22 | — | 0.73 | |
| Market value of equity / total liabilities | 11.02 | — | 6.61 | |
| Sales / total assets | 1.64 | — | 1.64 | |
| Altman Z-score | Safe zone | 11.69 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 9.65 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| CHE Chemed Corporation | 11.7× |
| NHC National HealthCare Corporation compare | 5.0× |
| OPCH Option Care Health, Inc. compare | 3.9× |
| ENSG The Ensign Group, Inc. compare | 3.6× |
| UHS Universal Health Services, Inc. compare | 3.3× |
| LFST LifeStance Health Group, Inc. compare | 2.6× |
| PACS PACS Group, Inc. compare | 2.0× |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 1.9× |
| CON Concentra Group Holdings Parent, Inc. compare | 1.8× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets